You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Moodys
Mallinckrodt
Baxter
McKesson

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEGARELIX ACETATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Degarelix Acetate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00215683 An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer Completed Ferring Pharmaceuticals Phase 2/Phase 3 2005-02-01 This was an extension study for the study FE200486 CS12 (NCT00819156). Each participant was to be treated until he was discontinued or withdrawn from the study, or a marketing authorization for degarelix had been obtained. The study was terminated when all ongoing participants had been treated for at least 5 years (including one year in the main study).
NCT00946920 A Trial of Degarelix in Patients With Prostate Cancer Completed Ferring Pharmaceuticals Phase 3 2009-06-01 A phase 3, open-label, parallel group, one year trial comparing the efficacy and safety of degarelix 3-month depot with the established therapy goserelin acetate 3-month implant in patients with prostate cancer.
NCT01220869 A Study of Degarelix in Taiwanese Patients With Prostate Cancer Completed Ferring Pharmaceuticals Phase 3 2010-12-01 A phase III trial investigating the efficacy and safety of degarelix one-month depot in Taiwanese patients with prostate cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Degarelix Acetate

Condition Name

Condition Name for Degarelix Acetate
Intervention Trials
Prostate Cancer 13
Stage III Prostate Cancer 4
Stage IV Prostate Cancer 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Degarelix Acetate
Intervention Trials
Prostatic Neoplasms 25
Adenocarcinoma 9
Breast Neoplasms 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Degarelix Acetate

Trials by Country

Trials by Country for Degarelix Acetate
Location Trials
United States 78
Canada 6
Mexico 4
Hungary 3
Germany 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Degarelix Acetate
Location Trials
Texas 5
Washington 5
New York 4
Colorado 4
Maryland 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Degarelix Acetate

Clinical Trial Phase

Clinical Trial Phase for Degarelix Acetate
Clinical Trial Phase Trials
Phase 4 1
Phase 3 6
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Degarelix Acetate
Clinical Trial Phase Trials
Recruiting 9
Not yet recruiting 9
Completed 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Degarelix Acetate

Sponsor Name

Sponsor Name for Degarelix Acetate
Sponsor Trials
National Cancer Institute (NCI) 8
Ferring Pharmaceuticals 7
Sidney Kimmel Comprehensive Cancer Center 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Degarelix Acetate
Sponsor Trials
Other 39
Industry 14
NIH 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Merck
Harvard Business School
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.